Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team

Review the latest evidence-based strategies for HR-positive/HER2-negative early breast cancer with an on-demand webcast downloadable slides from a live presentation series a series of expert commentaries a downloadable patient resource and a patient&rsquo s story podcast.

Share

Program Content

Activities

HR-Positive/HER2-Negative EBC
Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 14, 2023

Expires: March 13, 2024

View Activity

Activities

HR+/HER2- EBC Patient Resource
HR-Positive/HER2-Negative Early Breast Cancer Patient Resource: Questions for Your Care Team
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

View Activity

Activities

High-Risk HR+/HER2- EBC
Improving Outcomes for Patients With High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Education and Resources for the Multidisciplinary Team
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 04, 2023

Expires: January 03, 2024

View Activity

Activities

Risk in HR+/HER2  EBC
How Risk of Recurrence in HR-Positive/HER2-Negative Early Breast Cancer Impacts Therapeutic Choices
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2022

Expires: November 13, 2023

View Activity
Adj Abemaciclib in EBC: AE Management
Optimizing Patient Outcomes and Quality of Life With Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer Through Adverse Event Management
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2023

Expires: January 30, 2024

View Activity
EBC: Strategies for Adherence
Strategies to Maintain Adherence and Persistence to Oral Therapies in Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 13, 2023

View Activity
Patient Communication in EBC
Strategies for Optimizing Patient Communication: Focus on Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2023

View Activity

Activities

Patient Experience With HR+/HER2- EBC
A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2022

Expires: December 12, 2023

View Activity

Activities

Patient Story: Communication
My Journey as a Patient With Early Breast Cancer: The Importance of Communication
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 16, 2022

Expires: November 15, 2023

View Activity

Faculty

cover img faculity

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Chair, Breast Disease Committee
Texas Oncology
Sarah Cannon Research Institute
Dallas, Texas

cover img faculity

Joyce O’Shaughnessy, MD

Co-Director, Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
US Oncology
Dallas, Texas

cover img faculity

Julia LaBarbera, MSN, RN, AGACNP-BC

  • Nurse Practitioner
    Division of Hematology/Oncology
    Department of Medicine
    University of California, Los Angeles
    Santa Monica, California

cover img faculity

Julia LaBarbera, MSN, RN, AGACNP-BC

Nurse Practitioner
UCLA Hematology Oncology
Los Angeles, California

cover img faculity

Zoe Lanham

Patient

cover img faculity

Reshma Mahtani, DO

Chief of Breast Medical Oncology
Miami Cancer Center
Baptist Health South Florida
Miami, Florida

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly